NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-099-2001-0-PCT-02 Mitochondrial Topoisomerase 1 PCT PCT PCT/US02/04607 Abandoned
NCI E-190-2000-0-EP-03 Methods and Compositions For Inhibiting HIV-Coreceptor Interactions EP National Stage 02723190.1 Abandoned
NCI E-190-2000-0-AU-05 Methods and Compositions For Inhibiting HIV-Coreceptor Interactions AU National Stage 2002253984 Abandoned
NCI E-190-2000-0-CA-04 Methods and Compositions For Inhibiting HIV-Coreceptor Interactions CA National Stage 2438515 Abandoned
NHLBI E-082-2001-0-US-02 Real Time, Interactive, Volumetric Magnetic Resonance Imaging US National Stage 10/076,882 8068893 Expired PDF
NHLBI E-082-2001-0-PCT-03 REAL-TIME, INTERACTIVE VOLUMETRIC MRI PCT PCT PCT/US2002/004537 Expired
NIDDK E-148-2002-0-US-01 Generation of Mouse Cell Lines Lacking Expresion of X1alpha and GSalpha US 60/355,054 Abandoned
NCI E-145-2003-0-US-01 A Phase II Clinical Trail Of Anethole Dithiolethione (Sialor) In Smokers With Bronchial Dysplasia US 60/355,826 Abandoned
NCI E-310-2001-0-US-01 Identification of Potential Ovarian Cancer Tumor Markers and Therapeutic Targets US 60/357,031 Abandoned
NICHD E-286-1998-1-US-06 ORALLY ACTIVE PEPTIDES THAT PREVENT CELL DAMAGE AND DEATH US National Stage 10/049,587 7384908 Abandoned PDF
NIEHS E-204-1999-0-US-03 Ttp-Related Zinc Finger Domains and Methods of Use US National Stage 10/049,586 7238473 Expired PDF
NCI E-314-2001-0-PCT-02 Nucleic Acids of The Human ABCA12 Gene, Vectors Containing Such Nucleic Acids And Uses Thereof PCT PCT PCT/US02/001978 Expired
NCI E-314-2001-0-US-03 Nucleic Acids of The Human ABCA12 Gene, Vectors Containing Such Nucleic Acids And Uses Thereof US ORD 10/072,900 Abandoned
NIMH E-168-1999-0-US-03 COMPOSITIONS CONTAINING IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION FOR INDUCING IMMUNE TOLERANCE TO A GRAFT US National Stage 09/959,006 Abandoned
NCI E-058-2003-0-US-02 Generation Of Biomaterial Microarrays By Laser Transfer US ORD 10/068,364 6936311 Expired PDF
NCI E-058-2003-0-PCT-03 Generation Of Biomaterial Microarrays By Laser Transfer PCT PCT PCT/US2002/003950 Expired
NIA E-247-1997-0-US-14 HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS US DIV 10/071,488 6683105 Expired PDF
CC E-040-1997-0-US-04 Method for Segmenting Medical Images and Detecting surface Anomalies In Anatomical Structures US CON 10/072,667 6556696 Expired PDF
NCI E-276-2000-0-PCT-02 Method of Inhibiting Viral Replication Targeting the Nucleocapsid Protein PCT PCT PCT/US02/03592 Abandoned
NCI E-276-2000-0-EP-03 Method of Inhibiting Viral Replication Targeting the Nucleocapsid Protein EP National Stage 02726567.7 Abandoned
NIAID E-279-2001-0-US-01 Stem Cell Factor-Responsive FC&RI Bearing Human Mast Cell Line LAD2 US 60/354,440 Abandoned
NCI E-070-2001-0-AU-05 Chemical Compounds And Methods AU National Stage 2002227786 Expired
NCI E-018-1999-1-US-01 MOLECULAR MOTOR US CIP 10/061,377 7349834 Abandoned PDF
NCI E-070-2001-0-PCT-02 SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS PCT PCT PCT/AU2002/000099 Expired
NCI E-070-2001-0-JP-04 Chemical Compounds And Methods JP National Stage 2002-561023 Abandoned
NCI E-070-2001-0-EP-08 SYNTHESIS FOR THE PREPARATION OF COMPOUNDS FOR SCREENING AS POTENTIAL TUBULIN BINDING AGENTS EP National Stage 02709901.9 Abandoned
NCI E-101-2001-0-US-01 Nucleic Acid Analysis Using The Layered Scanning US 60/353,407 Abandoned
NIDDK E-147-2002-0-US-01 XANTHINE DERIVATIVES SUBSTITUTED HAVING A2B ADENOSINE ANTAGONIST ACTIVITY US 60/353,157 Abandoned
NCI E-070-2001-0-CA-03 Chemical Compounds And Methods CA National Stage 2435545 Abandoned
NIAID E-004-2004-2-US-02 Anti-Plasmodium Compositions and Methods of Use US National Stage 09/914,694 7025961 Expired PDF
NCI E-072-2001-0-PCT-02 Identification of New Small RNAs and ORFs of E. Coli as Mediators of Cell and lntercell Regulation PCT PCT PCT/US2002/003147 Expired
NIAAA E-251-2001-0-US-01 Method For Dectecting Nucleic Acid Sequence Variation. US 60/353,941 Abandoned
NCI E-009-1996-0-US-08 METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION AND ANGIOGENESIS US DIV 10/059,506 6846911 Abandoned PDF
NIEHS E-266-2007-0-US-01 New Opioid Derivative US ORD 10/058,192 6838580 Expired PDF
NCI E-113-1995-2-US-03 Extension of a Protein-Protein Interaction Surface to Inactivate The Function of a Cellular Protein US DIV 10/059,720 Abandoned
NCI E-116-2001-0-EP-33 Formulation of Boronic Acid Compounds EP DIV 10006835.2 Expired
NCI E-116-2001-0-CY-42 Formulation of Boronic Acid Compounds CY EP 10006835.2 Expired
NCI E-116-2001-0-LI-52 Formulation of Boronic Acid Compounds LI EP 10006835.2 Expired
NCI E-116-2001-0-LU-53 Formulation of Boronic Acid Compounds LU EP 10006835.2 Expired
NCI E-116-2001-0-MC-54 Formulation of Boronic Acid Compounds MC EP 10006835.2 Expired
NCI E-116-2001-0-PT-56 Formulation of Boronic Acid Compounds PT EP 10006835.2 Expired
NCI E-116-2001-0-NL-55 Formulation of Boronic Acid Compounds NL EP 10006835.2 Expired
NCI E-116-2001-0-GR-49 Formulation of Boronic Acid Compounds GR EP 10006835.2 Expired
NCI E-116-2001-0-IE-50 Formulation of Boronic Acid Compounds IE EP 10006835.2 Expired
NCI E-116-2001-0-IT-51 Formulation of Boronic Acid Compounds IT EP 10006835.2 Expired
NCI E-116-2001-0-AT-39 Formulation of Boronic Acid Compounds AT EP 10006835.2 Expired
NCI E-116-2001-0-BE-40 Formulation of Boronic Acid Compounds BE EP 10006835.2 Expired
NCI E-116-2001-0-DK-44 Formulation of Boronic Acid Compounds DK EP 10006835.2 Expired
NCI E-116-2001-0-DE-43 Formulation of Boronic Acid Compounds DE EP 10006835.2 Expired
NCI E-116-2001-0-FR-47 Formulation of Boronic Acid Compounds FR EP 10006835.2 Expired